Skip to main content
DongKoo Bio & Pharma Co., Ltd. logo

DongKoo Bio & Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 006620 ISIN · KR7006620009 KO Manufacturing
Open in API
Filings indexed 212 across all filing types
Latest filing 2023-12-22 Major Shareholding Noti…
Country KR South Korea
Listing KO 006620

About DongKoo Bio & Pharma Co., Ltd.

https://www.dongkoo.com/eng/

DongKoo Bio & Pharma Co., Ltd. is a biopharmaceutical company that manufactures and sells a range of pharmaceuticals and health supplements. The company holds a leading position in the dermatology prescription market, with a product portfolio that includes antihistamines, analgesics, antipyretics, and digestants. Strategically expanding beyond traditional pharmaceuticals, DongKoo Bio & Pharma is focused on the biotechnology sector, particularly the development of stem cell-based therapies. This growth is pursued through an "Open Innovation" model to build a pipeline of differentiated products, supported by its research centers and PIC/s compliant GMP manufacturing facilities.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, specifically regarding collateral contracts (pledges) by the major shareholder and special related parties of Dongkoo Bio & Pharma. This type of filing is a mandatory disclosure for significant shareholding changes and does not fit into categories like 10-K, ER, or DIRS (which is for individual director trades). It is a formal regulatory filing for major shareholding notifications.
2023-12-22 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal notice of the procedural steps required for the meeting. Given it is a standard regulatory disclosure regarding corporate governance and meeting preparation, it fits best under the general regulatory filing category.
2023-12-14 Korean
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement regarding the setting of a record date for dividend distribution (현금ㆍ현물배당을 위한 주주명부폐쇄(기준일) 결정). It specifies the dividend record date (2023-12-31) and the purpose (determining shareholders for the 41st fiscal year dividend). This falls under the category of dividend-related announcements.
2023-12-14 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Dongkoo Bio & Pharma regarding the decision to pay a cash dividend. It specifies the dividend amount per share, the record date, and the approval process. This falls directly under the definition of a 'Notice of Dividend Amount' (DIV).
2023-12-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea (often referred to as a '5% report' or 'Major Shareholding Notification'). It details the shareholding changes of the company's major shareholders and special related parties, including specific transaction dates, methods (e.g., market purchase), and the purpose of holding (management influence). This fits the definition of a Major Shareholding Notification (MRQ).
2023-11-15 Korean
분기보고서 (2023.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Dongkoo Bio&Pharma Co., Ltd. for the period ending September 30, 2023. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-11-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.